Latest return on equity
Nurix Therapeutics Return on equity
Direct answer
Nurix Therapeutics's return on equity is 43.99%.
The verified market snapshot reports 43.99%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 16, 2026.
Get free Nurix Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 43.99%
Explore related company data
View Nurix Therapeutics's market capitalizationView Nurix Therapeutics's p/e ratioView Nurix Therapeutics's price-to-book ratioView Nurix Therapeutics's dividend yieldView Nurix Therapeutics's 52-week price rangeView Nurix Therapeutics's revenue growthView Nurix Therapeutics's profit marginView Nurix Therapeutics's debt-to-equity ratioView all Nurix Therapeutics key metricsReturn to Nurix Therapeutics profile